STARR-CRAAVT: A platform to design cell type-specific regulatory elements for next-generation gene therapy

No abstract is available for this paper.

• Publication year

  2025

• Venue

  bioRxiv

• Publication date

  2025-06-07

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1101/2025.06.04.657008
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Short tandem repeats are important contributors to silencer elements in T cells

  2023cited by this paper
• Nonlinear control of transcription through enhancer–promoter interactions

  2022cited by this paper
• An Unbiased AAV-STARR-Seq Screen Revealing the Enhancer Activity Map of Genomic Regions in the Mouse Brain in Vivo

  2022influential reference
• Identification of Broadly Applicable Adeno-Associated Virus Vectors by Systematic Comparison of Commonly Used Capsid Variants In Vitro

  2022cited by this paper
• Compatibility rules of human enhancer and promoter sequences

  2022cited by this paper
• Parallel functional testing identifies enhancers active in early postnatal mouse brain

  2021cited by this paper
• Mechanisms of enhancer action: the known and the unknown

  2021cited by this paper
• Development of a Bispecific Antibody-Based Platform for Retargeting of Capsid Modified AAV Vectors

  2021cited by this paper
• A Small-Molecule-Responsive Riboswitch Enables Conditional Induction of Viral Vector-Mediated Gene Expression in Mice.

  2020cited by this paper
• Health

  2020cited by this paper
• Genome

  2020cited by this paper
• GENCODE 2021

  2020cited by this paper
• A systematic evaluation of the design and context dependencies of massively parallel reporter assays

  2020cited by this paper
• Expanded encyclopaedias of DNA elements in the human and mouse genomes

  2020cited by this paper
• Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays

  2020cited by this paper
• Journey to the Center of the Cell: Tracing the Path of AAV Transduction.

  2020cited by this paper
• Functional characterization of enhancer evolution in the primate lineage

  2018cited by this paper
• Targeting neuronal and glial cell types with synthetic promoter AAVs in mice, non-human primates and humans

  2018cited by this paper
• The chromatin accessibility landscape of primary human cancers

  2018cited by this paper
• Functional Dissection of the Enhancer Repertoire in Human Embryonic Stem Cells

  2017cited by this paper
• Gene Therapy with BMN 270 Results in Therapeutic Levels of FVIII in Mice and Primates and Normalization of Bleeding in Hemophilic Mice

  2017cited by this paper
• Functional assessment of human enhancer activities using whole-genome STARR-sequencing

  2017cited by this paper
• Resolving systematic errors in widely-used enhancer activity assays in human cells

  2017cited by this paper
• Hemophilia B Gene Therapy with a High‐Specific‐Activity Factor IX Variant

  2017cited by this paper
• The selection and function of cell type-specific enhancers

  2015cited by this paper
• Transcriptional enhancers: from properties to genome-wide predictions

  2014cited by this paper
• Functional and topological characteristics of mammalian regulatory domains

  2014cited by this paper
• Enhancer–core-promoter specificity separates developmental and housekeeping gene regulation

  2014cited by this paper
• featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

  2013cited by this paper
• Genome-Wide Quantitative Enhancer Activity Maps Identified by STARR-seq

  2013cited by this paper
• The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote

  2013influential reference
• Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.

  2013cited by this paper
• Fast gapped-read alignment with Bowtie 2

  2012cited by this paper
• Systematic Comparison of Constitutive Promoters and the Doxycycline-Inducible Promoter

  2010cited by this paper
• Solution Hybrid Selection with Ultra-long Oligonucleotides for Massively Parallel Targeted Sequencing

  2009cited by this paper
• Self-complementary AAV vectors; advances and applications.

  2008cited by this paper
• Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle.

  2007cited by this paper
• Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver.

  2006cited by this paper
• Concatamerization of Adeno-Associated Virus Circular Genomes Occurs through Intermolecular Recombination

  1999cited by this paper
• In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.

  1997cited by this paper
• Transcriptional enhancer elements in the mouse immunoglobulin heavy chain locus.

  1983cited by this paper
• A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene.

  1983cited by this paper
• Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences.

  1981cited by this paper
• Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features

  year unknowninfluential reference

• No citing papers are available for this paper.